Galantamine in advanced moderate Alzheimer's disease: Long-term benefits and the effect of delayed initiation of treatment

被引：0

作者：

Blesa, R

van Baelen, B

Kavanagh, S

机构：

[1] Hosp Santa Creu & Sant Pau, Neurol Serv, Barcelona, Spain

[2] Medisearch Int, Dept Biostat, Mechelen, Belgium

[3] Janssen Pharmaceut, Beerse, Belgium

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷

关键词：

D O I：

10.1016/S0924-977X(04)80451-6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S334 / S334

页数：1

共 50 条

[1] The long-term benefits of galantamine in "advanced-moderate" Alzheimer's disease patients.
Blesa, R
Reichman, W
Schwalen, S
Kershaw, P
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S81 - S82
[2] Long-term cognitive benefits of galantamine treatment in patients with Alzheimer's disease
Wessel, T
Gaens, E
ANNALS OF NEUROLOGY, 2000, 48 (03) : 461 - 461
[3] Galantamine provides long-term behavioral benefits in patients with mild to moderate Alzheimer's disease
Bullock, R
Kershaw, P
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S209
[4] Galantamine, a novel treatment for Alzheimer's disease: A review of long-term benefits to patients and caregivers
Tariot, P
Winblad, B
ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 707 - 723
[5] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
Feldman, H
Van Baelen, B
Brashear, HR
Schwalen, S
Kavanagh, S
NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
[6] A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease
Wilcock, G
Howe, I
Coles, H
Lilienfeld, S
Truyen, L
Zhu, Y
Bullock, R
DRUGS & AGING, 2003, 20 (10) : 777 - 789
[7] A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease
Gordon Wilcock
Ian Howe
Hilary Coles
Sean Lilienfeld
Luc Truyen
Young Zhu
Roger Bullock
Paul Kershaw
Drugs & Aging, 2003, 20 : 777 - 789
[8] Galantamine provides long-term benefits to caregivers of patients with Alzheimer's disease.
Borson, S
Sadik, K
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S105 - S105
[9] Galantamine produces long-term cognitive and functional benefits in patients with Alzheimer's disease
Raskind, M
Peskind, E
Parys, W
Wessel, T
NEUROLOGY, 2000, 54 (07) : A468 - A468
[10] A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: A responder analysis
Bullock, R
Mahableshwarkar, AR
Lilienfeld, S
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 250 - 251

← 1 2 3 4 5 →